Breast-fed infants have Bifidobacterium-rich gut microbiota compared to infants fed formula. Fucosylated oligosaccharides are the major components of human milk oligosaccharide (HMO) which confer various beneficial effects including prebiotic effect and protection from pathogenic infection on the host. A novel prebiotics was developed using bifidobacterial β-galactosidase and fucose and lactose as substrates. Structure analysis revealed it as β-D-galactopyranosyl-(1 → 3)-O-L-fucopyranose named as β-galactosyl fucose (gal-fuc), which is different from common fucosylated HMOs with α1–2, α1–3, and α1–4 linkages. Among the four Lactobacillus strains examined, all but L. delbrueckii subsp. bilgaricus KCTC 3635 grew better on gal-fuc than on β-GOS. Among the 11 bifidobacterial species examined, all except for B. bifium used gal-fuc as much as GOS. Moreover, the gal-fuc was noticeably better used by Bifidobacterium infantis, the major intestinal bacteria of breast fed infant. Among 15 non-probiotic bacteria, only 4 strains used gal-fuc better than β-GOS. In conclusion, a novel gal-fuc is expected to contribute to beneficial changes of gut microbiota.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Yu, Z.-T., Chen, C., Kling, D.E., Liu, B., McCoy, J.M., Merighi, M., Heidtman, M., Newburg, D.S.: The principal fucosylated oligosaccharides of human milk exhibit prebiotic properties on cultured infant microbiota. Glycobiology. 23(2), 169–177 (2012)
Oozeer, R., van Limpt, K., Ludwig, T., Amor, K.B., Martin, R., Wind, R.D., Boehm, G., Knol, J.: Intestinal microbiology in early life: specific prebiotics can have similar functionalities as human-milk oligosaccharides. Am. J. Clin. Nutr. 98(2), 561S–571S (2013)
Barile, D., Rastall, R.A.: Human milk and related oligosaccharides as prebiotics. Curr. Opin. Biotechnol. 24(2), 214–219 (2013)
Marcobal, A., Barboza, M., Froehlich, J.W., Block, D.E., German, J.B., Lebrilla, C.B., Mills, D.A.: Consumption of human milk oligosaccharides by gut-related microbes. J. Agric. Food Chem. 58(9), 5334–5340 (2010)
Ashida, H., Miyake, A., Kiyohara, M., Wada, J., Yoshida, E., Kumagai, H., Katayama, T., Yamamoto, K.: Two distinct α-l-fucosidases from Bifidobacterium bifidum are essential for the utilization of fucosylated milk oligosaccharides and glycoconjugates. Glycobiology. 19(9), 1010–1017 (2009)
Mackie, R.I., Sghir, A., Gaskins, H.R.: Developmental microbial ecology of the neonatal gastrointestinal tract. Am. J. Clin. Nutr. 69(5), 1035s–1045s (1999)
Radke, M., Picaud, J.-C., Loui, A., Cambonie, G., Faas, D., Lafeber, H.N., de Groot, N., Pecquet, S.S., Steenhout, P.G., Hascoet, J.-M.: Starter formula enriched in prebiotics and probiotics ensures normal growth of infants and promotes gut health: a randomized clinical trial. Pediatr. Res. 81(4), 622–631 (2016)
Lam, K.-L., Cheung, P.C.-K.: Non-digestible long chain beta-glucans as novel prebiotics. Bioactive carbohydrates and dietary fibre. 2(1), 45–64 (2013)
Costalos, C., Kapiki, A., Apostolou, M., Papathoma, E.: The effect of a prebiotic supplemented formula on growth and stool microbiology of term infants. Early Hum. Dev. 84(1), 45–49 (2008)
Moro, G., Minoli, I., Mosca, M., Fanaro, S., Jelinek, J., Stahl, B., Boehm, G.: Dosage-related bifidogenic effects of galacto-and fructooligosaccharides in formula-fed term infants. J. Pediatr. Gastroenterol. Nutr. 34(3), 291–295 (2002)
Vos, A.P., Haarman, M., Buco, A., Govers, M., Knol, J., Garssen, J., Stahl, B., Boehm, G., M'rabet, L.: A specific prebiotic oligosaccharide mixture stimulates delayed-type hypersensitivity in a murine influenza vaccination model. Int. Immunopharmacol. 6(8), 1277–1286 (2006)
Arslanoglu, S., Moro, G.E., Boehm, G.: Early supplementation of prebiotic oligosaccharides protects formula-fed infants against infections during the first 6 months of life. J. Nutr. 137(11), 2420–2424 (2007)
Moro, G., Arslanoglu, S., Stahl, B., Jelinek, J., Wahn, U., Boehm, G.: A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Arch. Dis. Child. 91(10), 814–819 (2006)
German, J., Freeman, S., Lebrilla, C., Mills, D.: Human milk oligosaccharides: evolution, structures and bioselectivity as substrates for intestinal bacteria. In: Personalized Nutrition for the Diverse Needs of Infants and Children, vol. 62, pp. 205–222. Karger Publishers (2008)
Bode, L.: Recent advances on structure, metabolism, and function of human milk oligosaccharides. J. Nutr. 136(8), 2127–2130 (2006)
Yu, Z.-T., Chen, C., Newburg, D.S.: Utilization of major fucosylated and sialylated human milk oligosaccharides by isolated human gut microbes. Glycobiology. 23(11), 1281–1292 (2013)
Tao, N., DePeters, E., Freeman, S., German, J.B., Grimm, R., Lebrilla, C.B.: Bovine milk glycome. J. Dairy Sci. 91(10), 3768–3778 (2008)
Newburg, D.S., Ruiz-Palacios, G.M., Morrow, A.L.: Human milk glycans protect infants against enteric pathogens. Annu. Rev. Nutr. 25, 37–58 (2005)
Ma, B., Simala-Grant, J.L., Taylor, D.E.: Fucosylation in prokaryotes and eukaryotes. Glycobiology. 16(12), 158R–184R (2006)
Murata, T., Morimoto, S., Zeng, X., Watanabe, S., Usui, T.: Enzymatic synthesis of α-l-fucosyl-N-acetyllactosamines and 3′-O-α-l-fucosyllactose utilizing α-l-fucosidases. Carbohydr. Res. 320(3), 192–199 (1999)
Usvalampi, A., Maaheimo, H., Tossavainen, O., Frey, A.D.: Enzymatic synthesis of fucose-containing galacto-oligosaccharides using β-galactosidase and identification of novel disaccharide structures. Glycoconj. J. 35(1), 31–40 (2018)
Pickard, J.M., Chervonsky, A.V.: Intestinal fucose as a mediator of host–microbe symbiosis. J. Immunol. 194(12), 5588–5593 (2015)
Prudden, A.R., Liu, L., Capicciotti, C.J., Wolfert, M.A., Wang, S., Gao, Z., Meng, L., Moremen, K.W., Boons, G.-J.: Synthesis of asymmetrical multiantennary human milk oligosaccharides. Proc. Natl. Acad. Sci. 114(27), 6954–6959 (2017)
Seeberger, P.H.: Automated carbohydrate synthesis to drive chemical glycomics. Chem. Commun. (10), 1115–1121 (2003)
Chen, W., Chen, H., Xia, Y., Zhao, J., Tian, F., Zhang, H.: Production, purification, and characterization of a potential thermostable galactosidase for milk lactose hydrolysis from Bacillus stearothermophilus. J. Dairy Sci. 91(5), 1751–1758 (2008)
Oh, S., Youn, S., Park, M., Kim, H., Baek, N., Li, Z., Ji, G.: Synthesis of β-galactooligosaccharide using bifidobacterial β-galactosidase purified from recombinant Escherichia coli. J. Microbiol. Biotechnol. (2017)
Vigsnaes, L.K., Nakai, H., Hemmingsen, L., Andersen, J.M., Lahtinen, S.J., Rasmussen, L.E., Hachem, M.A., Petersen, B.O., Duus, J.Ø., Meyer, A.S.: In vitro growth of four individual human gut bacteria on oligosaccharides produced by chemoenzymatic synthesis. Food Funct. 4(5), 784–793 (2013)
Candela, M., Seibold, G., Vitali, B., Lachenmaier, S., Eikmanns, B.J., Brigidi, P.: Real-time PCR quantification of bacterial adhesion to Caco-2 cells: competition between bifidobacteria and enteropathogens. Res. Microbiol. 156(8), 887–895 (2005)
Coppa, G.V., Zampini, L., Galeazzi, T., Facinelli, B., Ferrante, L., Capretti, R., Orazio, G.: Human milk oligosaccharides inhibit the adhesion to Caco-2 cells of diarrheal pathogens: Escherichia coli, Vibrio cholerae, and Salmonella fyris. Pediatr. Res. 59(3), 377–382 (2006)
Fuller, Z., Louis, P., Mihajlovski, A., Rungapamestry, V., Ratcliffe, B., Duncan, A.J.J.B.J.o.N.: Influence of cabbage processing methods and prebiotic manipulationof colonic microflora on glucosinolate breakdown in man. 98(2), 364–372 (2007)
Bode, L., Jantscher-Krenn, E.: Structure-function relationships of human milk oligosaccharides. Advances in Nutrition: An International Review Journal. 3(3), 383S–391S (2012)
Zivkovic, A.M., German, J.B., Lebrilla, C.B., Mills, D.A.: Human milk glycobiome and its impact on the infant gastrointestinal microbiota. Proc. Natl. Acad. Sci. 108(Supplement 1, 4653–4658 (2011)
Xiao, Z., Guo, Y., Liu, Y., Li, L., Zhang, Q., Wen, L., Wang, X., Kondengaden, S.M., Wu, Z., Zhou, J.: Chemoenzymatic synthesis of a library of human milk oligosaccharides. The Journal of organic chemistry. 81(14), 5851–5865 (2016)
Ninonuevo, M.R., Park, Y., Yin, H., Zhang, J., Ward, R.E., Clowers, B.H., German, J.B., Freeman, S.L., Killeen, K., Grimm, R.: A strategy for annotating the human milk glycome. J. Agric. Food Chem. 54(20), 7471–7480 (2006)
Ajisaka, K., Shirakabe, M.: Regioselective synthesis of α-L-fucosyl-containing disaccharides by use of α-L-fucosidases of various origins. Carbohydr. Res. 224, 291–299 (1992)
LoCascio, R.G., Niñonuevo, M.R., Kronewitter, S.R., Freeman, S.L., German, J.B., Lebrilla, C.B., Mills, D.A.: A versatile and scalable strategy for glycoprofiling bifidobacterial consumption of human milk oligosaccharides. Microb. Biotechnol. 2(3), 333–342 (2009)
Asakuma, S., Hatakeyama, E., Urashima, T., Yoshida, E., Katayama, T., Yamamoto, K., Kumagai, H., Ashida, H., Hirose, J., Kitaoka, M.: Physiology of consumption of human milk oligosaccharides by infant gut-associated bifidobacteria. J. Biol. Chem. 286(40), 34583–34592 (2011)
Bode, L.: Human milk oligosaccharides: every baby needs a sugar mama. Glycobiology. 22(9), 1147–1162 (2012)
Behnsen, J., Deriu, E., Sassone-Corsi, M., Raffatellu, M.: Probiotics: properties, examples, and specific applications. Cold Spring Harbor perspectives in medicine. 3(3), a010074 (2013)
Ruiz-Palacios, G.M., Cervantes, L.E., Ramos, P., Chavez-Munguia, B., Newburg, D.S.: Campylobacter jejuni binds intestinal H (O) antigen (Fucα1, 2Galβ1, 4GlcNAc), and fucosyloligosaccharides of human milk inhibit its binding and infection. J. Biol. Chem. 278(16), 14112–14120 (2003)
Newburg, D.S.: Neonatal protection by an innate immune system of human milk consisting of oligosaccharides and glycans. J. Anim. Sci. 87(13_suppl), 26–34 (2009)
This work was carried out with support from the National Research Foundation of Korea (NRF) grant (No. 2017R1A2B2012390) funded by the Korea government (MSIP), High Value-added Food Technology Development Program (No. 317043-3), Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (IPET), Ministry of Agriculture, Food and Rural Affairs (MAFRA), and the Technological Innovation R&D Program (No. S2463318) funded by the Small and Medium Business Administration, Republic of Korea.
Conflict of interest
The authors declare that they have no conflicts of interest.
This article does not contain any studies with human participants or animals performed by any of the authors.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Oh, SY., Park, MS., Lee, YG. et al. Enzymatic synthesis of β-galactosyl fucose using recombinant bifidobacterial β-galactosidase and its prebiotic effect. Glycoconj J 36, 199–209 (2019). https://doi.org/10.1007/s10719-019-09871-5
- β-Galactosyl fucose
- Bifidobacterium longum subsp. longum RD 47
- Human milk oligosaccharide